Charles River Laboratories and Zacks Investment Research

Selected news for the company - Charles River Laboratories, and the capital firm - Zacks Investment Research. We have 177 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/11/2022 Charles River Laboratories International (NYSE:CRL) Releases FY22 Earnings Guidance Charles River Laboratories International (NYSE:CRL) issued an update on its FY22 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $11.50-11.75 for the period, compared to the Thomson Reuters ... a buy rating in a report on Tuesday, November 16th. Zacks Investment Research cut Charles River Laboratories International from a buy rating to a hold rating and set a $458.00 price objective for the company ...
1/11/2022 Charles River Laboratories International (NYSE:CRL) Shares Gap Up to $334.11 - The Cerbat Gem Charles River Laboratories International, Inc. (NYSE:CRL) shares gapped up before the market opened on Tuesday . The stock had previously closed at $334.11, but opened at $343.17. Charles River Laboratories International shares last traded at ... the stock in a research note on Thursday, November 4th. Zacks Investment Research lowered Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 target price on ...
1/11/2022 Charles River Laboratories International (NYSE:CRL) Shares Gap Up to $334.11 - Watch List News Charles River Laboratories International, Inc. (NYSE:CRL)‚Aos share price gapped up prior to trading on Tuesday . The stock had previously closed at $334.11, but opened at $343.17. Charles River Laboratories International shares last traded ... Laboratories International in a research note on Thursday, October 14th. Zacks Investment Research downgraded Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price objective for ...
1/5/2022 Charles River Laboratories International (NYSE:CRL) Trading Down 4.1% Charles River Laboratories International, Inc. (NYSE:CRL)‚Aos share price traded down 4.1% during trading on Monday . The stock traded as low as $360.89 and last traded at $361.39. 2,701 shares were traded during mid ... Aubuy‚Au rating in a report on Tuesday, November 16th. Zacks Investment Research cut Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price target for ...
1/3/2022 Charles River Laboratories International (NYSE:CRL) Trading Down 4.1% Charles River Laboratories International, Inc. (NYSE:CRL) shares traded down 4.1% during mid-day trading on Monday . The company traded as low as $360.89 and last traded at $361.39. 2,701 shares were traded during mid ... the company in a research report on Thursday, November 4th. Zacks Investment Research downgraded Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price objective for ...
10/14/2021 Charles River Laboratories International's (CRL) ‚ÄúBuy‚Äù Rating Reiterated at Evercore ISI - Mayfield Recorder Mayfield Recorder Charles River Laboratories International (NYSE:CRL) ‚Aos stock had its ‚Aubuy‚Au rating restated by equities research analysts at Evercore ISI in a report released on Thursday, AnalystRatings.com reports.Several other research firms also recently commented on CRL. Zacks Investment Research downgraded shares of Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price target for the company. in a research ...
10/14/2021 Charles River Laboratories International (NYSE:CRL) Receives Buy Rating from Evercore ISI American Banking News Charles River Laboratories International (NYSE:CRL)‚Aos stock had its ‚Aubuy‚Au rating reaffirmed by research analysts at Evercore ISI in a research report issued to clients and investors on Thursday, AnalystRatings.com reports.A number ... Au rating in a research report on Thursday, August 5th. Zacks Investment Research lowered shares of Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price ...
10/7/2021 Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of ‚ÄúBuy‚Äù by Analysts Shares of Charles River Laboratories International, Inc. (NYSE:CRL) have received a consensus rating of ‚AuBuy‚Au from the fifteen research firms that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have ... Au rating in a research report on Thursday, August 5th. Zacks Investment Research lowered shares of Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 target ...
9/29/2021 Charles River Laboratories International (NYSE:CRL) Trading Down 4.8% Charles River Laboratories International, Inc. (NYSE:CRL) shares traded down 4.8% during trading on Monday . The company traded as low as $433.85 and last traded at $436.29. 1,737 shares were traded during mid-day trading ... rating in a research note on Thursday, August 5th. Finally, Zacks Investment Research lowered Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price objective for ...
9/25/2021 Charles River Laboratories International (NYSE:CRL) Hits New 12-Month High at $456.33 Charles River Laboratories International, Inc. (NYSE:CRL)‚Aos share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $456.33 and last traded at $455.85, with ... Au rating in a research report on Thursday, August 5th. Zacks Investment Research cut Charles River Laboratories International from a ‚Aubuy‚Au rating to a ‚Auhold‚Au rating and set a $458.00 price target on ...
9/25/2021 Charles River Laboratories International (NYSE:CRL) Reaches New 52-Week High at $456.33 Charles River Laboratories International, Inc. (NYSE:CRL)‚Aos share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $456.33 and last traded at $455.85, with a volume of 2583 shares. The stock had previously closed at $446.34. A number of research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Charles River Laboratories International from ...
9/16/2021 Charles River Laboratories International (NYSE:CRL) Lowered to ‚ÄúHold‚Äù at Zacks Investment Research The Markets Daily Zacks Investment Research cut shares of Charles River Laboratories International (NYSE:CRL) from a buy rating to a hold rating in a research note released on Wednesday, Zacks.com reports. They currently have $458.00 price target on the medical research company‚Aos stock. According to Zacks, ‚AuCharles River exited the second quarter of 2021 on a strong note, with better-than-expected revenues and earnings. Robust demand in the Biologics Testing ...
8/31/2021 Zacks: Brokerages Anticipate Charles River Laboratories International, Inc. (NYSE:CRL) Will Post Quarterly Sales of $898.97 Million Wall Street analysts expect Charles River Laboratories International, Inc. (NYSE:CRL) to report $898.97 million in sales for the current fiscal quarter, according to Zacks . Five analysts have issued estimates for Charles River Laboratories International ... billion, with estimates ranging from $3.75 billion to $4.02 billion. Zacks Investment Research‚Aos sales averages are a mean average based on a survey of analysts that that provide coverage for Charles River Laboratories International ...
8/31/2021 Charles River Laboratories International, Inc. (NYSE:CRL) Expected to Announce Quarterly Sales of $898.97 Million - WKRB News Analysts expect Charles River Laboratories International, Inc. (NYSE:CRL) to announce sales of $898.97 million for the current fiscal quarter, according to Zacks Investment Research . Five analysts have made estimates for Charles River Laboratories International‚Aos earnings, with the lowest sales estimate coming in at $865.02 million and the highest estimate coming in at $917.20 million. Charles River Laboratories International posted sales of $743.30 million in the same quarter last ...
8/31/2021 Charles River Laboratories International (NYSE:CRL) Hits New 1-Year High at $446.61 - Slater Sentinel Shares of Charles River Laboratories International, Inc. (NYSE:CRL) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $446.61 and last traded at $444.06, with a ... Auoverweight‚Au rating in a report on Friday, May 14th. Zacks Investment Research raised Charles River Laboratories International from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating and set a $460.00 target price on ...
8/30/2021 Charles River Laboratories International (NYSE:CRL) Rating Increased to Buy at Zacks Investment Research The Markets Daily Zacks Investment Research upgraded shares of Charles River Laboratories International (NYSE:CRL) from a hold rating to a buy rating in a research note issued to investors on Friday morning, Zacks.com reports. Zacks Investment Research currently has $460.00 target price on the medical research company‚Aos stock. According to Zacks, ‚AuCharles River exited the second quarter of 2021 on a strong note, with better-than-expected revenues and earnings. Robust ...
8/27/2021 Argus Increases Charles River Laboratories International (NYSE:CRL) Price Target to $480.00 Charles River Laboratories International (NYSE:CRL) had its price target upped by Argus from $390.00 to $480.00 in a report published on Monday, The Fly reports. The firm currently has a buy rating on the ... overweight rating in a research report on Friday, May 28th. Zacks Investment Research raised Charles River Laboratories International from a hold rating to a buy rating and set a $361.00 price objective on the stock ...
8/27/2021 Charles River Laboratories International (NYSE:CRL) Reaches New 12-Month High at $431.35 - Transcript Daily Charles River Laboratories International, Inc. (NYSE:CRL) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $431.35 and last traded at $431.35, with a volume of ... Au rating in a research report on Thursday, August 5th. Zacks Investment Research upgraded shares of Charles River Laboratories International from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating and set a $361.00 target ...
8/27/2021 Charles River Laboratories International (NYSE:CRL) Upgraded to ‚ÄúBuy‚Äù at Zacks Investment Research - Transcript Daily Charles River Laboratories International (NYSE:CRL) was upgraded by Zacks Investment Research from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating in a research note issued to investors on Friday, Zacks.com reports. The brokerage presently has a $460.00 target price on the medical research company‚Aos stock. Zacks Investment Research ‚Aos target price suggests a potential upside of 3.91% from the stock‚Aos current price.According to Zacks, ‚AuCharles ...
8/26/2021 Zacks: Analysts Expect Charles River Laboratories International, Inc. (NYSE:CRL) to Announce $2.56 Earnings Per Share - Transcript Daily Equities analysts expect Charles River Laboratories International, Inc. (NYSE:CRL) to report earnings of $2.56 per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Charles River Laboratories International‚Aos earnings, with the highest EPS estimate coming in at $2.62 and the lowest estimate coming in at $2.46. Charles River Laboratories International reported earnings of $2.33 per share during the same quarter last ...
8/25/2021 Charles River Laboratories International (NYSE:CRL) Sets New 12-Month High at $431.35 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) reached a new 52-week high during trading on Wednesday . The stock traded as high as $431.35 and last traded at $431.35, with a volume of ... Au rating in a research note on Thursday, August 5th. Zacks Investment Research upgraded Charles River Laboratories International from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating and set a $361.00 target price on ...
8/23/2021 Charles River Laboratories International, Inc. (NYSE:CRL) Expected to Post Quarterly Sales of $898.97 Million - Transcript Daily Wall Street brokerages expect that Charles River Laboratories International, Inc. (NYSE:CRL) will post $898.97 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Charles River Laboratories International‚Aos earnings. The highest sales estimate is $917.20 million and the lowest is $865.02 million. Charles River Laboratories International posted sales of $743.30 million during the same quarter last year, which would suggest a ...
8/23/2021 Argus Raises Charles River Laboratories International (NYSE:CRL) Price Target to $480.00 Charles River Laboratories International (NYSE:CRL) had its price target upped by investment analysts at Argus from $390.00 to $480.00 in a research report issued on Monday, The Fly reports. The brokerage currently has a ... Auoutperform‚Au rating in a report on Thursday, August 5th. Zacks Investment Research raised shares of Charles River Laboratories International from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating and set a $361.00 price ...
8/20/2021 Charles River Laboratories International (NYSE:CRL) Updates FY 2021 Earnings Guidance Charles River Laboratories International (NYSE:CRL) updated its FY 2021 earnings guidance on Wednesday. The company provided earnings per share guidance of $10.100-$10.350 for the period, compared to the Thomson Reuters consensus earnings per ... neutral rating in a research note on Thursday, August 5th. Zacks Investment Research raised Charles River Laboratories International from a hold rating to a buy rating and set a $361.00 price target for the company ...
8/19/2021 Charles River Laboratories International (NYSE:CRL) Price Target Increased to $465.00 by Analysts at UBS Group Charles River Laboratories International (NYSE:CRL) had its target price upped by research analysts at UBS Group from $390.00 to $465.00 in a report released on Tuesday, The Fly reports. The firm presently has a ... Au rating in a research report on Friday, May 14th. Zacks Investment Research upgraded shares of Charles River Laboratories International from a ‚Auhold‚Au rating to a ‚Aubuy‚Au rating and set a $361.00 target ...